Citation: Js. Reese et al., MGMT expression in murine bone marrow is a major determinant of animal survival after alkylating agent exposure, J HEMATH ST, 10(1), 2001, pp. 115-123
Authors:
Ishikawa, T
Ide, F
Qin, XS
Zhang, SM
Takahashi, T
Sekiguchi, M
Tanaka, K
Nakatsuru, Y
Citation: T. Ishikawa et al., Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies, MUT RES-F M, 477(1-2), 2001, pp. 41-49
Authors:
Liu, L
Spiro, TP
Qin, XS
Majka, S
Haaga, J
Schupp, J
Willson, JKV
Gerson, SL
Citation: L. Liu et al., Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O-6-benzylguanine, CLIN CANC R, 7(8), 2001, pp. 2318-2324
Authors:
Zhou, H
Chen, WD
Qin, XS
Lee, K
Liu, LL
Markowitz, SD
Gerson, SL
Citation: H. Zhou et al., MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice, ONCOGENE, 20(42), 2001, pp. 6009-6017
Citation: Xs. Qin et al., Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea, CARCINOGENE, 21(4), 2000, pp. 833-838
Citation: Xs. Qin et al., Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT, ONCOGENE, 18(30), 1999, pp. 4394-4400
Citation: Xs. Qin et al., Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis, CARCINOGENE, 20(9), 1999, pp. 1667-1673
Citation: Ll. Liu et al., Reduced lung tumorigenesis in human methylguanine DNA-methyltransferase transgenic mice achieved by expression of transgene within the target cell, CARCINOGENE, 20(2), 1999, pp. 279-284